Does a targeting ligand influence nanoparticle tumor localization or uptake? - PubMed (original) (raw)
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Kathleen F Pirollo et al. Trends Biotechnol. 2008 Oct.
Abstract
Inclusion of a tumor-targeting molecule in nanosized delivery systems increases their in vivo efficacy. However, the biodistribution and pharmacokinetics of the uptake of such particles have not yet been well addressed. Several recent papers have suggested that tumor-targeting ligands function primarily to increase intracellular uptake of the nanocomplex and do not influence tumor localization. However, other reports indicate that they do play a role in the accumulation in the tumor. One difference might be the presence or absence of poly-[ethylene glycol] (PEG) in the complex and its impact on the enhanced permeability and retention (EPR) effect. Further studies are clearly needed to more fully elucidate the influence of composition on tumor-targeted, systemic delivery of nanoparticles.
Similar articles
- Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH, Lin YY, Hwang JJ, Wang HE, Tseng YL, Wang SJ, Liu RS, Lin WJ, Yang CS, Ting G. Chow TH, et al. Anticancer Res. 2009 Jun;29(6):2111-20. Anticancer Res. 2009. PMID: 19528471 - In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size.
Fang C, Shi B, Pei YY, Hong MH, Wu J, Chen HZ. Fang C, et al. Eur J Pharm Sci. 2006 Jan;27(1):27-36. doi: 10.1016/j.ejps.2005.08.002. Epub 2005 Sep 16. Eur J Pharm Sci. 2006. PMID: 16150582 - Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
McNeeley KM, Karathanasis E, Annapragada AV, Bellamkonda RV. McNeeley KM, et al. Biomaterials. 2009 Aug;30(23-24):3986-95. doi: 10.1016/j.biomaterials.2009.04.012. Epub 2009 May 9. Biomaterials. 2009. PMID: 19427688 - Passive and active drug targeting: drug delivery to tumors as an example.
Torchilin VP. Torchilin VP. Handb Exp Pharmacol. 2010;(197):3-53. doi: 10.1007/978-3-642-00477-3_1. Handb Exp Pharmacol. 2010. PMID: 20217525 Review. - Exploiting the enhanced permeability and retention effect for tumor targeting.
Iyer AK, Khaled G, Fang J, Maeda H. Iyer AK, et al. Drug Discov Today. 2006 Sep;11(17-18):812-8. doi: 10.1016/j.drudis.2006.07.005. Drug Discov Today. 2006. PMID: 16935749 Review.
Cited by
- Hybrid Lymphatic Drug Delivery Vehicles as a New Avenue for Targeted Therapy: Lymphatic Trafficking, Applications, Challenges, and Future Horizons.
Harisa GI, Sherif AY, Alanazi FK. Harisa GI, et al. J Membr Biol. 2023 Jun;256(3):199-222. doi: 10.1007/s00232-023-00280-2. Epub 2023 Feb 8. J Membr Biol. 2023. PMID: 36752839 Free PMC article. Review. - Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery.
Cobley CM, Au L, Chen J, Xia Y. Cobley CM, et al. Expert Opin Drug Deliv. 2010 May;7(5):577-87. doi: 10.1517/17425240903571614. Expert Opin Drug Deliv. 2010. PMID: 20345327 Free PMC article. Review. - Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors.
Satpathy M, Wang L, Zielinski R, Qian W, Lipowska M, Capala J, Lee GY, Xu H, Wang YA, Mao H, Yang L. Satpathy M, et al. Small. 2014 Feb 12;10(3):544-55. doi: 10.1002/smll.201301593. Epub 2013 Aug 27. Small. 2014. PMID: 24038985 Free PMC article. - Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivo.
Ong HT, Trejo TR, Pham LD, Oberg AL, Russell SJ, Peng KW. Ong HT, et al. Mol Ther. 2009 Jun;17(6):1012-21. doi: 10.1038/mt.2009.39. Epub 2009 Mar 10. Mol Ther. 2009. PMID: 19277014 Free PMC article. - Design considerations for nanotherapeutics in oncology.
Stylianopoulos T, Jain RK. Stylianopoulos T, et al. Nanomedicine. 2015 Nov;11(8):1893-907. doi: 10.1016/j.nano.2015.07.015. Epub 2015 Aug 15. Nanomedicine. 2015. PMID: 26282377 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources